N
Nyra Medical
Developing a novel transcatheter mitral and tricuspid valve repair technology
About Nyra Medical
Nyra Medical is a pioneering medical device company focused on developing advanced transcatheter mitral and tricuspid valve repair technologies. Headquartered in Atlanta, Georgia, with engineering operations in Pforzheim, Germany, and Minneapolis, Minnesota, Nyra Medical aims to simplify and personalize heart valve repair procedures. The company’s innovative approach ensures consistent correction of valve regurgitation—a condition where the heart's valves do not close properly, causing blood to flow backward.
Read full description
Nyra Medical serves a diverse range of clients, primarily targeting healthcare providers, cardiologists, and hospitals that specialize in cardiovascular treatments. The company operates in the highly specialized medical device market, specifically within the cardiovascular segment, which is a rapidly growing field due to the increasing prevalence of heart diseases globally.
The business model of Nyra Medical revolves around the development, manufacturing, and sale of its proprietary heart valve repair devices. These devices are designed to be safe, effective, and adaptable to each patient's unique needs, ensuring better outcomes and fewer side effects. By focusing on early intervention in the disease process, Nyra Medical aims to provide long-term solutions that preserve future treatment options for patients.
Nyra Medical generates revenue through the sale of its medical devices to hospitals and healthcare providers. Additionally, the company may engage in partnerships and collaborations with other medical institutions and technology firms to expand its market reach and enhance its product offerings.
In summary, Nyra Medical is at the forefront of transforming heart valve repair with its cutting-edge technology, dedicated to improving patient outcomes and advancing cardiovascular care.
At a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Atlanta, United States
- Employees
- 24
- Open positions
- None listed
- Dealroom signal
- 79.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, medical implants, Cardiology and cardiovascular, Spinout, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Nyra Medical.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Nov 2022 | $20M | $80M | Broadview Ventures · Epidarex Capital · Georgia Research Alliance · Vensana Capital | ↗ |
| SPINOUT✓Other financing | Jan 2021 | $0 | — | Emory University | — |
Growth signals
Latest recorded traffic for Nyra Medical is 1.5K monthly website visits, down 55.9% over the last three months. Nyra Medical's team grew 14.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Vensana Capital
Broadview Ventures
Epidarex Capital
Georgia Research Alliance
Other known investors2 additional known investors
Emory University
GRA Venture Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Nyra Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nyra Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.